Kertesz N J, Towbin J A, Clunie S, Fenrich A L, Friedman R A, Kearney D L, Dreyer W J, Price J F, Radovancevic B, Denfield S W
Lillie Frank Abercrombie Section of Pediatric Cardiology, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.
J Heart Lung Transplant. 2003 Aug;22(8):889-93. doi: 10.1016/s1053-2498(02)00805-7.
Arrhythmias in adult orthotopic heart transplant (OHT) recipients are common and have been used as predictors of rejection. Because of the paucity of information in pediatric OHT recipients, the purpose of this study was to determine the incidence and correlation of arrhythmias with rejection or with coronary artery disease (CAD) in children.
We retrospectively reviewed the records, electrocardiograms (ECGs), and 24-hour ambulatory ECGs of patients who underwent OHT from January 1984 to December 1999. We excluded arrhythmias occurring in the first 2 weeks after OHT.
Sixty-nine patients underwent OHT, received triple-immunosuppression therapy, were discharged home, and have been followed for a mean of 4.7 years (0.3-13 years). Each patient had an average of 10 ECGs and three 24-hour ECGs. Twenty-six patients had 33 arrhythmias: sinus bradycardia (n = 9), atrial tachycardia (n = 9), ventricular tachycardia (n = 3), and Wenckebach periodicity (n = 6). Sinus bradycardia was treated with theophylline in 8 patients, and 2 required pacemakers. Atrial tachycardias (atrial flutter in 4 patients and atrial ectopic tachycardia in 5) were treated with digoxin, propranolol, or procainamide. Ventricular tachycardia was treated with mexiletine, lidocaine, and amiodarone. There were 65 episodes of rejection, 20 of which were moderate/severe (> or =3B). Only Wenckebach was associated with the presence of either rejection or CAD (p < 0.05).
We noted clinically significant arrhythmias in 38% of the pediatric OHT recipients. Sinus bradycardia, atrial tachyarrhythmias, and ventricular tachycardia occurred with the same frequency. Only new-onset Wenckebach periodicity was noted in the presence of either CAD or rejection. No arrhythmia was of negative predictive value for rejection or CAD. From this data, we suggest that new-onset Wenckebach prompt evaluation for rejection or CAD.
成人原位心脏移植(OHT)受者心律失常很常见,并已被用作排斥反应的预测指标。由于小儿OHT受者的相关信息匮乏,本研究旨在确定儿童心律失常的发生率以及心律失常与排斥反应或冠状动脉疾病(CAD)之间的相关性。
我们回顾性分析了1984年1月至1999年12月期间接受OHT患者的病历、心电图(ECG)及24小时动态心电图。我们排除了OHT术后前2周内发生的心律失常。
69例患者接受了OHT,接受三联免疫抑制治疗后出院,并平均随访4.7年(0.3 - 13年)。每位患者平均有10份心电图和3次24小时心电图。26例患者发生了33次心律失常:窦性心动过缓(n = 9)、房性心动过速(n = 9)、室性心动过速(n = 3)和文氏周期(n = 6)。8例窦性心动过缓患者使用茶碱治疗,2例需要起搏器。房性心动过速(4例为心房扑动,5例为房性异位心动过速)采用地高辛、普萘洛尔或普鲁卡因胺治疗。室性心动过速采用美西律、利多卡因和胺碘酮治疗。发生65次排斥反应,其中20次为中度/重度(≥3B)。只有文氏周期与排斥反应或CAD的存在相关(p < 0.05)。
我们发现38%的小儿OHT受者存在具有临床意义的心律失常。窦性心动过缓、房性快速性心律失常和室性心动过速的发生率相同。仅在存在CAD或排斥反应时出现新发文氏周期。没有心律失常对排斥反应或CAD具有阴性预测价值。根据这些数据,我们建议对新发文氏周期患者进行排斥反应或CAD的快速评估。